Janux Therapeutics Inc (JANX)

08:48 AM

Janux appoints Janeen Doyle chief corporate, business development officer - TipRanks

08:48 AM

08:45 AM

Janux Therapeutics (JANX) Welcomes New Chief Corporate and Busin - GuruFocus

08:45 AM

08:30 AM

Janux Therapeutics (JANX) Welcomes New Chief Corporate and Business Development Officer | JANX Stock News - GuruFocus

08:30 AM

08:02 AM

Janux Therapeutics Appoints Janeen Doyle as Chief Corporate and Business Development Officer - Bluefield Daily Telegraph

08:02 AM

May 14, 2025

Janux Therapeutics Reports Increased Q1 Losses Amid R&D Expansion - TipRanks

May 14, 2025

May 13, 2025

Trend Tracker for (JANX) - news.stocktradersdaily.com

May 13, 2025

May 12, 2025

Leerink cuts Janux Therapeutics price target to $89, keeps Outperform By Investing.com - Investing.com India

May 12, 2025

May 09, 2025

Promising Pipeline and Strategic Advancements Justify Buy Rating for Janux Therapeutics Inc - TipRanks

May 09, 2025

May 09, 2025

Janux Therapeutics price target lowered to $36 from $41 at Scotiabank - TipRanks

May 09, 2025

May 09, 2025

Janux Therapeutics (JANX) Reports Q1 EPS Loss, Maintains Strong Cash Position - GuruFocus

May 09, 2025

May 09, 2025

Scotiabank Adjusts Janux Therapeutics (JANX) Price Target Amid T - GuruFocus

May 09, 2025

May 09, 2025

Positive Buy Rating for Janux Therapeutics Inc. Driven by Promising Clinical Data and Strong Financial Position - TipRanks

May 09, 2025

May 09, 2025

Decoding Janux Therapeutics Inc (JANX): A Strategic SWOT Insight - GuruFocus

May 09, 2025

May 08, 2025

Janux Therapeutics Reports First Quarter 2025 Financial Results and Business Highlights - BioSpace

May 08, 2025

May 08, 2025

Janux Therapeutics Inc: Undervalued Growth Potential Amid Recent Stock Pullback - TipRanks

May 08, 2025

May 08, 2025

Janux Therapeutics Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 08, 2025

May 08, 2025

Janux Therapeutics (JANX) Advances Clinical Trials for JANX007 | JANX Stock News - GuruFocus

May 08, 2025

May 08, 2025

Janux Therapeutics reports Q1 EPS (38c), consensus (39c) - TipRanks

May 08, 2025

May 08, 2025

BRIEF-Janux Therapeutics Q1 Basic EPS USD -0.38 - TradingView

May 08, 2025

May 08, 2025

Buy Rating for Janux Therapeutics Inc. Driven by Strategic Advancements in Prostate Cancer Treatment with JANX007 - TipRanks

May 08, 2025

May 06, 2025

Janux Therapeutics (NASDAQ:JANX) Shares Gap Down After Insider Selling - Defense World

May 06, 2025

May 06, 2025

Buy Rating for Janux Therapeutics Inc: Promising PFS Data and Attractive Valuation - TipRanks

May 06, 2025

May 06, 2025

Janux commences Phase Ib studies in trial for prostate cancer treatment - Yahoo

May 06, 2025

May 05, 2025

Buy Rating for Janux Therapeutics Inc: Promising Clinical Trial Results and Positive Outlook for JANX007 - TipRanks

May 05, 2025

May 05, 2025

Janux Therapeutics Inc expected to post a loss of 39 cents a shareEarnings Preview - TradingView

May 05, 2025

May 05, 2025

Janux Therapeutics, Inc. (JANX): Among Unknown Billionaire Phill Gross’ Stock Picks with Huge Upside Potential - Insider Monkey

May 05, 2025

May 05, 2025

Janux Therapeutics begins phase 1b trial for prostate cancer therapy - Investing.com

May 05, 2025

May 05, 2025

Janux Therapeutics begins phase 1b trial for prostate cancer therapy By Investing.com - Investing.com India

May 05, 2025

May 05, 2025

Janux Therapeutics Initiates Phase 1b Expansion Studies with JANX007 in Patients with Prostate Cancer and Provides Program Updates - Business Wire

May 05, 2025

May 05, 2025

Is Janux Therapeutics, Inc. (JANX) the Best Small Cap Stock to Buy with the Biggest Upside Potential? - Insider Monkey

May 05, 2025

May 04, 2025

Unknown Billionaire Phill Gross’ 10 Stock Picks with Huge Upside Potential - Insider Monkey

May 04, 2025

May 03, 2025

Top 11 Small Cap Stocks to Buy with Biggest Upside Potential - Insider Monkey

May 03, 2025

May 02, 2025

A new trading data show Janux Therapeutics Inc (JANX) is showing positive returns. - Sete News

May 02, 2025

May 02, 2025

Learn to Evaluate (JANX) using the Charts - news.stocktradersdaily.com

May 02, 2025

May 02, 2025

Trading Day Review: Janux Therapeutics Inc (JANX) Loses Momentum, Closing at 32.05 - DWinneX

May 02, 2025

May 02, 2025

Should Janux Therapeutics Inc (NASDAQ: JANX) Rally After -123.74% Drop From High? - Marketing Sentinel

May 02, 2025

May 02, 2025

Wells Fargo & Company MN Grows Stake in Janux Therapeutics, Inc. (NASDAQ:JANX) - Defense World

May 02, 2025

May 01, 2025

Are Janux Therapeutics Inc’shares a good deal? - uspostnews.com

May 01, 2025

Apr 30, 2025

Latest Insider moments: Meyer Andrew Hollman, Janux Therapeutics Inc [JANX] Chief Business Officer sold 3,334 shares – Knox Daily - knoxdaily.com

Apr 30, 2025

Apr 27, 2025

Russell Investments Group Ltd. Buys 442 Shares of Janux Therapeutics, Inc. (NASDAQ:JANX) - Defense World

Apr 27, 2025

Apr 26, 2025

Janux Therapeutics Inc (JANX) Worth Considering For The Next Few Weeks - Stocksregister

Apr 26, 2025

Apr 26, 2025

Legal & General Group Plc Boosts Stake in Janux Therapeutics, Inc. (NASDAQ:JANX) - American Banking and Market News

Apr 26, 2025

Apr 26, 2025

LPL Financial LLC Makes New $439,000 Investment in Janux Therapeutics, Inc. (NASDAQ:JANX) - Defense World

Apr 26, 2025

Apr 25, 2025

Financial Metrics Exploration: Understanding Heron Therapeutics Inc (HRTX) Through Ratios - DWinneX

Apr 25, 2025

Apr 25, 2025

Cerity Partners LLC Acquires Shares of 4,478 Janux Therapeutics, Inc. (NASDAQ:JANX) - Defense World

Apr 25, 2025

Apr 25, 2025

Janux Therapeutics, Inc. (NASDAQ:JANX) Receives Consensus Rating of “Buy” from Analysts - Defense World

Apr 25, 2025

Apr 25, 2025

Astera Labs, Inc. (NASDAQ:ALAB) Given Average Recommendation of “Buy” by Analysts - Defense World

Apr 25, 2025

Apr 24, 2025

Janux Therapeutics Inc (JANX)’s stock chart: A technical perspective - uspostnews.com

Apr 24, 2025

Apr 24, 2025

Janux Therapeutics Inc [JANX] Shares Rise 5.36 % on Wednesday - knoxdaily.com

Apr 24, 2025

Apr 23, 2025

Oncology’s Most Eligible Unpartnered Assets - insights.citeline.com

Apr 23, 2025

Apr 21, 2025

Janux Therapeutics, Inc. (NASDAQ:JANX) Shares Purchased by Invesco Ltd. - Defense World

Apr 21, 2025

Apr 17, 2025

Long Term Trading Analysis for (JANX) - news.stocktradersdaily.com

Apr 17, 2025

Apr 16, 2025

Geode Capital Management LLC Boosts Stock Position in Janux Therapeutics, Inc. (NASDAQ:JANX) - Defense World

Apr 16, 2025

Apr 15, 2025

JPMorgan Chase & Co. Boosts Holdings in Janux Therapeutics, Inc. (NASDAQ:JANX) - Defense World

Apr 15, 2025